Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM

Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM

Abstract The aim of this article is to demonstrate extreme interindividual variability of piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients and to emphasize the need for the practice of routine PIP/TAZO plasma concentrations measurement in order to ensure o...

Full description

Bibliographic Details
Main Authors: M. Mieresova, K. Balazova, J. Kubele, D. Cerny, M. Halacova
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Clinical Case Reports
Subjects:
critical illness
morbid obesity
piperacillin/tazobactam (PIP/TAZO)
therapeutic drug monitoring (TDM)
Online Access:https://doi.org/10.1002/ccr3.7032

Internet

https://doi.org/10.1002/ccr3.7032

Similar Items